ArticleNeuro-oncology2022

Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.

Michael Bockmayr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.